In-Q-Tel Invests in Febit

Xconomy Boston — 

Febit, a Heidelberg, Germany-based maker of automated, microfluidic gene and RNA sequencing devices with laboratories in Lexington, MA, said today that In-Q-Tel, the venture wing of the U.S. intelligence community, has made a strategic investment in the company. The size of the investment was not disclosed, but In-Q-Tel’s investments usually range between $1 million and $3 million, and are earmarked specifically for R&D in areas of interest to U.S. civilian and defense intelligence agencies. “Febit’s technology has the potential to become an important tool within the bio security sector,” In-Q-Tel partner Ben Levitan said in a statement.